14 Apr Annual report 2015 – Investing in the future

Aquaporin > News > News > Annual report 2015 – Investing in the future


The year 2015 was an important year for the Aquaporin Group as a number of significant achievements supported and strengthened our strategic foundation even further.

In the beginning of 2015, Danica Pension made a significant capital injection, which increased the investor base with another strong investor. The capital increase enabled the continued commercialization of our products, significant strengthening our organization, and the establishment of new headquarters in the Copenhagen area, Denmark.
The new headquarters will contain a large-scale production facility, which will support the demand from our customers and Strategic Commercial Partnership agreements. Relocation to the new headquarters takes place in the spring of 2016.

From Strategic Commercial Partnership to Joint Venture
On the Chinese marked, Aquaporin established a joint venture company, Aquapoten Company Ltd. The joint venture company is an off-spring of the strategic commercial partnership agreement from 2014 between Aquaporin and our two Chinese partners, Heilongjiang Interchina Water Treatment (Interchina) and Poten Environment (Poten). Aquapoten is the commercialization and production hub into the Chinese market. The joint venture will commence sales to the Chinese market in 2016 starting with membranes for household purifiers. The joint venture has at present 20 employees in China, and is aiming for 45 employees by the end of 2016.

“Aquapoten is the first Strategic Commercial Partnership for Aquaporin, and proves the strength of partnering in the commercialization of the Aquaporin Inside™ technology. We are working dedicated to strengthen our Strategic Commercial Partnership base in 2016”, says CEO Peter Holme Jensen.

Going into Space
The test of Aquaporin Inside™ membranes has continued in different applications and the membranes were tested in the International Space Station’s water re-cycling system during 2015. Further tests in space are to take place in 2016.

Expansion and Production
The Aquaporin A/S organization and Aquaporin Asia Pte. organizations were expanded, matured and tuned for future growth in order to support the transition from a research and development focused company to an operating company with large-scale production capabilities. Large commercial scale production lines were ordered in 2015, and are to be set-up and implemented during 2016 in the new headquarters in Copenhagen.

Financial highlights
The income statement of the Company for 2015 shows a net loss of DKK 16 million. Aquaporin incurred research and development costs for DKK 18 million of which DKK 5 million were capitalized. Sales and distribution costs amounted to DKK 4 million and administrative costs amounted to DKK 8 million.

At December 31, 2015 the balance sheet of the Company shows a total balance of DKK 179 million compared to DKK 107 million December 31, 2014. Total non-current assets amounted to DKK 84 million December 31, 2015 compared to DKK 37 million December 31, 2014. The increase is driven by investments in the new headquarters including large-scale production facility and development projects.

Shareholders equity amounts to DKK 176 million December 31, 2015 compared to DKK 105 million December 31, 2014. The capital injection from Danica Pension is the contributor to the increase in equity.

Cash and cash equivalent increased by DKK 16 million in 2015 and is DKK 81 million December 31, 2015.

For further information:
CEO, Peter Holme Jensen, phone +45 82 30 30 82
VP Finance, Bo Karmark, phone +45 82 30 30 82

Read the full press release here


Invalid email.
Get your newsletter about: